Risks of Parenteral Deferoxamine for Acute Iron Poisoning

References

• Reissmann K. R., Coleman T. J., Budai B. S., et al. Acute intestinal iron intoxication 1. Iron absorption, serum iron and autopsy findings. Blood 1955; 10: 35–45
   PubMed Web of Science ®Google Scholar
• Vernon D. D., Banner W., Jr., Dean I. M. Hemodynamic effects of experimental iron poisoning. Ann Emerg Med 1989; 18: 863–866
   PubMed Web of Science ®Google Scholar
• Whitten C. F., Chen Y. C., Gibson G. W. Studies in acute iron poisoning HI: The hemodynamic alterations in acute experimental iron poisoning. Ped Res 1968; 2: 479–485
   PubMed Web of Science ®Google Scholar
• Leikin S., Vossough P., Mochiv-Fatemi F. Chelation therapy in acute iron poisoning. J Peds 1969; 71: 425–430
   Web of Science ®Google Scholar
• Douglas D., Smilkstein M. Deferoxamine-ironinduced pulmonary injury and Nacetylcysteine. J Toxicol Clin Toxicol 1995; 33: 495
   Google Scholar
• Fontecave M., Pierre J. L. Iron: metabolism, toxicity and therapy. Biochimie 1993; 75: 767–773
   PubMed Web of Science ®Google Scholar
• Hersho C., Weatherall D. Iron chelating therapy. CRC Rev in Oin Lab Sci 1988; 26: 303–345
   PubMed Web of Science ®Google Scholar
• Aust S. D., Chignell C. F., Bray T. M., Kalyanaraman B., Mason R. P. Contemporary issues in toxicology. Free radicals in toxicology. Toxicol Appl Pharmacol 1993; 120: 168–178
   PubMed Web of Science ®Google Scholar
• Halliwell B. Protection against tissue damage in vivo by desferrroxamine: What is its mechanism of action?. Free Radic Biol Med 1989; 7: 645–651
   PubMed Web of Science ®Google Scholar
• Halliwell B., Gutteridge J. M. C. Role of iron in oxygen radical reactions. Methods Enzymol 1984; 105: 47–56
   PubMed Web of Science ®Google Scholar
• Ryan T. P., Aust S. D. The role of iron in oxygen mediated toxicities. Crit Rev Toxicol 1992; 22: 119–141
   PubMed Web of Science ®Google Scholar
• Keberle H. The biochemistry of deferoxanine and its relation to iron metabolism. Ann NY Acad Sci 1964; 119: 758–768
   PubMed Web of Science ®Google Scholar
• Peters G., Keberle K., Schmid K., Brunner H. Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and rat. Biochem Pharmacol 1966; 15: 93–109
   PubMed Web of Science ®Google Scholar
• Lee P., Mohammed N., Marshal L., et al. Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients. Drug Metab Dispos 1993; 21: 640–644
   PubMed Web of Science ®Google Scholar
• Summers M. R., Jacobs A., Tudway D., Perera P., Ricketts C. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects. Br J Haematol 1979; 42: 547–555
   PubMed Web of Science ®Google Scholar
• Whitten C. F., Gibson G., Good K., et al. Studies in acute iron poisoning II: Desferioxamine in the treatment of acute iron poisoning. Clinical observations, experimental studies, and theoretical considerations. Peds 1965; 36: 322–325
   PubMed Web of Science ®Google Scholar
• Whitten C. F., Chen Y. C., Gibson G. W. Studies in acute iron poisoning II: Further observations of desferoxamine in the treatment of acute experimental iron poisoning. Peds 1966; 38: 102–110
   PubMed Web of Science ®Google Scholar
• Westlin W. E. Deferoxamine in the treatment of acute iron poisoning. Clinical experiences with 172 children. Clin Pediatr Phila 1966; 5: 531–535
   PubMed Web of Science ®Google Scholar
• Tenenbein M., Kowalski S., Shenko A., Bowden D. H., Adamson I. Y. Pulmonary toxic effects of continuous desferrioxamine adminstration in acute iron poisoning. Lancet 1992; 339: 699–701
   PubMed Web of Science ®Google Scholar
• Isselbacher K. J., Braunwald E., Wilson J. D., et al. Harrison's Principles of Internal Medicine. McGraw-Hill, New York 1994; 1240
   Google Scholar
• Thompson J. Two cases of ferrous sulfate poisoning. Brit Med J 1947; II: 640
   Google Scholar
• Foucar M., Gordon B., Kaye S. Death foliovang ingestion of ferrous sulfate. Am J Clin Path 1948; 18: 971–973
   PubMed Web of Science ®Google Scholar
• Clark W. K., Jurow S. S., Walford R. L., Warthen R. O. Ferrous sulfate poisoning. AMA Am J Dis Child 1952; 220–226
   Google Scholar
• Lieut Branch. Ferrous sulfate poisoning - Report of a fatal case. Peds 1952; 10: 677–680
   PubMed Web of Science ®Google Scholar
• Duffy T. L., Diehl A. M. Report of three cases. J Peds 1952; 40: 1–5
   PubMed Web of Science ®Google Scholar
• Luongo M. A., Bjomson S. S. The liver in ferrous sulfate poisoning. A report of three fatal cases in children and an experimental study. N Engl J Med 1954; 251: 995–999
   PubMed Web of Science ®Google Scholar
• Hoppe J., Marcelli G., Taintenn M. A review of the toxicity of iron compounds. Am J Med Sci 1955; 558–571
   PubMed Web of Science ®Google Scholar
• Freedman M. H., Grisaru D., Olivieri N., MacLusky I., Thorner P. S. Pulmonary syndrome in patients vath thalessemiamajorreceivingintravenousdeferroxamine indusions. Am J Dis Child 1990; 144: 565–569
   PubMedGoogle Scholar
• Castriota Scanderberg A., Izzi G. C., Buttufini A., Benaglia G. Pulmonary syndrome and intravenous high-dose desferrioxamine. Lancet 1990; 336: 1511
   Web of Science ®Google Scholar
• Anderson K. J., Rivers R. P. A. Desferrioxamine in acute iron poisoning. Lancet 1992; 339: 1602
   PubMedGoogle Scholar
• Weitman S., Buchanan G., Karnen B. Pulmonary toxicity of deferroxamine in children with advanced cancer. J Natl Cancer Inst 1991; 83: 1834–1835
   PubMed Web of Science ®Google Scholar
• Miller Y., Rosenwasser L., Bessette J., et al. Rapid desensitisation for desferrioxamine anaphylactic reaction. Lancet 1981; i: 1059
   Google Scholar
• Helson L., Helson C., Braverman S., Deb G. Donfrancesco A. Desferrioxamine in acute iron poisoning. Lancet 1992; 339: 1602–1603
   PubMedGoogle Scholar
• Adamson I. Y., Sienko A., Tenenbein M. Pulmonary toxicity of deferoxamine in iron-poisoned mice. Toxicol Appl Pharmacol 1993; 120: 13–19
   PubMed Web of Science ®Google Scholar
• Davies S., Hungerford J., Arden G., et al. Ocular toxicity of high dose intravenous desferrioxamine. Lancet 1983; ii: 181–184
   Google Scholar
• Olivieri N. F., Buncic J. R., Chew E., et al. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 1986; 314: 869–873
   PubMed Web of Science ®Google Scholar
• Pengloan J., Dantal J., Rossazza K., Abazza M., Nivet H. Ocular toxicity after a single dose of desferrioxamine in two hemodialyzed patients. Nephron 1987; 46: 211–212
   PubMedGoogle Scholar
• Bene C., Manzler A., Bene D., Kranias G. Irreversible ocular toxicity from single “challenge” dose of deferoxamine. Clin Nephron 1989; 31: 45–48
   PubMed Web of Science ®Google Scholar
• Blake D. R., Winyard P., Lunec J., et al. Cerebral and ocular toxicity induced by dexferrioxamine. Q J Med 1985; 219: 345–355
   Google Scholar
• Porter J., Jaswon M., Huehns E., et al. Desferrioxamine ototoxicity: evaluation of risk factors in thallessemic patients and guidelines for safe dosage. Br J Haematol 1989; 73: 403–409
   PubMed Web of Science ®Google Scholar
• Simon P., Ang K. S., Meyrier A., Allain P., Mauras Y. Desferrioxamine, ocular toxicity and trace metals. Lancet 1983; ii: 512–513
   Google Scholar
• Pall H., Blake D. R., Winyard P., et al. Ocular toxicity of desferrioxamine - an example of copper promoted auto-oxidative damage?. Br J Ophthalmol 1989; 73: 42–47
   PubMed Web of Science ®Google Scholar
• Gerhlbach P. L., Purple R. L., Hallaway P. E., Hedlund B. E. Polymer conjugation reduces deferoxamine induced retinopathy in an albino rat model. Invest Ophthalmol Vis Sci 1993; 34: 2871–2877
   PubMed Web of Science ®Google Scholar
• Melby K., Slordahl S., Gutteberg T., Nordbo S. A. Septicaemia due to Yersinia enterocolitica after oral overdsoe of iron. Br Med J Clin Res Ed 1982; 285: 467–468
   PubMed Web of Science ®Google Scholar
• Mofenson H. C., Caraccio T. R., Sharieff N. Iron sepsis: Yersinia enterocolitica septicemia possibly caused by an overdose of iron. N Engl J Med 1987; 316: 1092–1093
   PubMed Web of Science ®Google Scholar
• Robins-Browne R. M., Prpic J. K. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun 1985; 47: 774–779
   PubMed Web of Science ®Google Scholar
• Boelaert J. R., de Locht M., Van Cutsem J., et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 1993; 91: 1979–1986
   PubMed Web of Science ®Google Scholar
• Bentur Y., McGuigan M., Koren G. G. Deferoxamine (desferroxamine), new toxicities for an old drug. DrugSaf 1991; 6: 37–46
   Google Scholar
• Propper R., Shurm S., Nathan D. Reassessment of the use of deferrioxamine B in iron overload. N Engl J Med 1976; 294: 1421–1423
   PubMed Web of Science ®Google Scholar
• Cheney K., Gumbiner C., Benson B., Tenenbein M. Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine. J Toxicol Clin Toxicol 1995; 33: 61–66
   PubMed Web of Science ®Google Scholar